CA1113044A — Personal repellant device
Assigned to Individual · Expires 1981-11-24 · 44y expired
What this patent protects
ABSTRACT OF THE DISCLOSURE A personal repellent device comprising a capsule having a perfor-ated outer shell composed of a deformable material and a rupturable sealed inner container disposed within the outer shell and adapted to contain a malodorous and/or irritating and/or debi…
USPTO Abstract
ABSTRACT OF THE DISCLOSURE A personal repellent device comprising a capsule having a perfor-ated outer shell composed of a deformable material and a rupturable sealed inner container disposed within the outer shell and adapted to contain a malodorous and/or irritating and/or debilatating substance.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.